Latest News

A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.

Channels: Cardiovascular Health, Heart Disease, Embargoed Feed - hidden, Medical Meetings,

Keywords: Peripheral Arterial Disease, Peripheral Arterial Disease (Pad), Statins, Heart Attack, Stroke, american heart association scientific sessions, American Heart Association, PAD, Intermountain Healthcare Heart Institute , intermountain healthcare

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Embargoed Feed - hidden,

Keywords: Omega 3 Fatty Acids, Omega 3, omega 3 supplements, Omega 3 Oils, Omega 3 Fatty Acids, Prostate Cancer, Heart Disease, Heart Attack, Stroke, Intermountain Healthcare Heart Institute , intermountain healthcare, american heart association scientific session, EPA, Metabolites

Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.

Channels: Cardiovascular Health, Genetics, Heart Disease, Embargoed Feed - hidden, Medical Meetings,

Keywords: Genetics, Heart Failure, non-ischemic dilated cardiomyopathy , NIDC, Cardiomyopathy, Mutations, Intermountain Healthcare Heart Institute , DNA, american heart association scientific sessions, American Heart Association

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in pediatric cardiology.

Channels: Exercise and Fitness, Pharmaceuticals, All Journal News, Cardiovascular Health, Children's Health, Clinical Trials, Heart Disease,

Keywords: pediatric cardiology, Congenital Heart Disease, single-ventricle disease, Clinical Trials, FUEL Trial, Pediatric Heart Network, Cardiology, Fontan procedure

Experts from 80 medical centers in the U.S., Canada and Norway will convene Nov. 15–17 in Baltimore, Maryland, to share best practices and performance improvement initiatives designed to reduce unnecessary tests, treatments and procedures and improve the overall value of health care.

Channels: Cardiovascular Health, Healthcare, Heart Disease, Embargoed Feed - hidden, Medical Meetings,

Keywords: High value health care, redundant imaging, Diabetes, Heart Murmur, Health Care Spending

In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don’t.

Channels: Cardiovascular Health, Food Science, Health Food, Healthcare, Nutrition, Public Health, Embargoed Feed - hidden, Medical Meetings,

Keywords: Intermittent Fasting, Heart, Cath Lab, Longevity, intermountain heakthcare, Cardiac Catheterization, Heart Attack, american heart association scientific sessions, Study, Research, Heart Health, Death

Women who are diagnosed with peripartum cardiomyopathy (PPCM) during late pregnancy or within a month following delivery are more likely to experience restored cardiac function and improved outcomes compared to those who are diagnosed later in the postpartum period.

Channels: All Journal News, Cardiovascular Health, Heart Disease, OBGYN, Race and Ethnicity, Women's Health, Embargoed Feed - hidden,

Keywords: Heart Disease In Women, Pregnancy, Cardiomyopathy, Preeclampsia, Penn Medicine

Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Pharmaceuticals,

Keywords: Cardiac, Heart Attack, Cholesterol, LDL, Medical Research, news releases, Dr. R. Scott Wright